Evidence map›Paper›PMID 42038617›Full record

ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2026

A tool based on objective data to identify patients at elevated risk of hospital-onset

Richard Silvera, Minji Jeon, Avi Ma'ayan, Judith Aberg, Bernard Camins, Stephanie H Factor

Abstract read
In one paragraph

Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Richard SilveraMedicine/Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, USA.ORCID https://orcid.org/0000-0001-7196-2483
Minji JeonKorea University College of Medicine, Republic of Korea.
Avi Ma'ayanIcahn School of Medicine at Mount Sinai, USA.ORCID https://orcid.org/0000-0002-6904-1017
Judith AbergMedicine/Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, USA.ORCID https://orcid.org/0000-0001-8162-0284
Bernard CaminsMedicine/Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, USA.
Stephanie H FactorMedicine/Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, USA.ORCID https://orcid.org/0000-0003-0125-8639

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Identify patients at increased risk of hospital-onset Design: Nested case-control study. Setting: A large, inner city, tertiary care center between January 1, 2011 and August 31, 2020. Participants: 375 cases and 2,248 matched controls. Methods: All hospitalized persons ≥18 years, found to have SA bacteremia at least 48 hours after admission were matched to 1-12 controls on birth year, race/ethnicity, sex, and month and year of admission. Vital signs and lab results were coded as "low" or "high" based on laboratory definitions. Multivariable models identified patient characteristics associated with an increased risk of SA bacteremia. Results: SA bacteremia was associated with high aspartate aminotransferase (AST) (>35 u/L )(HR = 1.92, 95%CI (1.30, 2.83), Conclusions: A prediction tool applied on admission of hospital stay ≥15 days OR any elevated two of the following: AST, creatinine, CO2, or total protein has sensitivity between 57%-64% and specificity to between 65%-78%.

Identifiers

PMID42038617
PMCPMC13104533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.